Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

Disha Malani, Ashwini Kumar, Oscar Brück, +24

Cancer Discovery

AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells

Maria L. Lotsberg, Katarzyna Wnuk-Lipińska, Stéphane Terry, +22

Journal of Thoracic Oncology

Efficient in vivo vascularization of tissue-engineering scaffolds

Anja Hegen, Anna Blois, Crina Tiron, +5

Journal of Tissue Engineering and Regenerative Medicine

Early response evaluation by single cell signaling profiling in acute myeloid leukemia

Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, +21

Nature Communications

Mixed-phenotype Acute LeukemiaProtein Kinase 2Aberrant Pro-survival SignalingTumor BiologyMyeloid Neoplasia +15

Titrating Complex Mass Cytometry Panels

Stein‐Erik Gullaksen, Lucius Bader, Monica Hellesøy, +6

Cytometry Part A

EngineeringBackbone PanelMicroscopyImmunologyImmunophenotyping +17

Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types

Muntasir Mamun Majumder, Aino‐Maija Leppä, Monica Hellesøy, +14

Haematologica

Innate Drug SensitivityImmunologyMalignant Cell TypesTumor BiologyHematological Malignancy +14

Sex disparity in acute myeloid leukaemia with <i>FLT3</i> internal tandem duplication mutations: implications for prognosis

Monica Hellesøy, Caroline Engen, Tim Grob, +3

Molecular Oncology

Abstract 1747: BGB324, a selective small molecule Axl kinase inhibitor to overcome EMT-associated drug resistance in carcinomas: Therapeutic rationale and early clinical studies

Katarzyna Wnuk-Lipińska, Crina Tiron, Gro Gausdal, +14

Cancer Research

Abstract 1747Emt-associated Drug ResistanceCancer BiologyTumor BiologyOncology +15

FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation

Caroline Engen, Monica Hellesøy, Tim Grob, +7

Molecular Oncology

Mixed-phenotype Acute LeukemiaGeneticsGenetic EpidemiologyPathologyFlt3‐itd Mutations +21

Cellular context–mediated Akt dynamics regulates MAP kinase signaling thresholds during angiogenesis

Monica Hellesøy, James B. Lorens

Molecular Biology of the Cell

EngineeringEndothelial CellsAkt Kinase ActivityCellular PhysiologyAngiogenesis +21